Clinical Trials
Linerixibat (GSK2330672), a drug that is being developed for PBC patients who experience itchiness, has recently been granted “orphan” status by the FDA. This is
September 24, 2019
No Comments
Blog
Category: PBC News
- Home
- Category: PBC News
Clinical Trials
As a result of extremely promising results of Phase 2 trials, Cymabay Therapeutics is now enrolling patients in a Phase 3 study for Seladelpar. This
September 23, 2019
No Comments
PBC News
Read the results of our patient survey which was initiated in 2015, with more than 250 PBC patients reporting how PBC affects their daily lives.
April 4, 2019
No Comments
Clinical Trials
Genkyotex “published interim efficacy results today, GKT831 met both it’s primary and secondary endpoints in the Phase II PBC trial! A big thank you to the
November 6, 2018
No Comments
The Toronto Centre for Liver Disease recently published a graphic that explains how specialists diagnose PBC. Thanks to Dr. Gideon Hirschfield and Marwa Ismail for
October 26, 2018
No Comments
PBC News
Thanks to the Gastrointestinal Society in association with the Canadian Society of Intestinal Research for this excellent graphic describing Liver Cirrhosis and providing you with
October 26, 2018
No Comments
Clinical Trials
Novartis has cancelled its phase II trial for a non-bile acid FXR agonist in patients with PBC.
October 19, 2018
No Comments
PBC News
A new study from the University of Calgary shows the antidepressant, Mitrazapine, may help PBC. In April Dr Abdel Aziz presented the promising results. Read more
June 23, 2018
No Comments
Clinical Trials
More exciting news for PBC patients and their families. Arena Pharmaceutical is beginning a proof of concept clinical trial in Australia and New Zealand for
March 23, 2018
No Comments
PBC News
At the AASLD 2017 Liver Meeting, an abstract was presented, by Dr. van der Meer et al titled “Ursodeoxycholic Acid is Associated with Prolonged Transplant-free
October 27, 2017
No Comments